Table 1.
Baseline characteristics of 3,251 MESA participants.
| Annualized 25-OH-vitamin D [ng/ml] | PTH [pg/ml] | |||||||
|---|---|---|---|---|---|---|---|---|
| <20 (n=1033) |
20.0–29.9 (n=1155) |
>=30.0 (n=1063) |
<33.0 (n=964) |
33.0–44.2 (n=962) |
44.3–64.9 (n=955) |
>=65 (n=370) |
||
| Age [y] | 58.8 (9.1) | 60.6 (9.4) | 61.6 (9.4) | 58.8 (9.1) | 60.6 (9.4) | 61.6 (9.4) | 58.8 (9.1) | |
| Male, % | 446 (43.3%) | 576 (50%) | 456 (46%) | 446 (43.3%) | 576 (50%) | 456 (46%) | 446 (43.3%) | |
| Race / ethnicity, % | White | 194 (18.8%) | 472 (41%) | 621 (58.5%) | 481 (49.9%) | 400 (41.6%) | 318 (33.3%) | 88 (24%) |
| Chinese | 102 (9.9%) | 195 (16.9%) | 133 (12.5%) | 170 (17.6%) | 149 (15.5%) | 95 (10%) | 16 (4.4%) | |
| Black | 507 (49.2%) | 225 (19.5%) | 106 (10%) | 151 (15.7%) | 221 (23%) | 315 (33%) | 151 (41.3%) | |
| Hispanic | 228 (22.1%) | 260 (22.6%) | 202 (19%) | 162 (16.8%) | 191 (20%) | 226 (23.7%) | 111 (30.3%) | |
| Treated diabetes, % | 106 (10.3%) | 104 (9%) | 54 (5.1%) | 90 (9.4%) | 66 (6.9%) | 72 (7.6%) | 35 (9.8%) | |
| Hypertension, % | 460 (44.6%) | 471 (40.9%) | 310 (36.4%) | 310 (32.2%) | 356 (37%) | 447 (46.9%) | 205 (56%) | |
| Treatment for hypertension, % | 376 (36.5%) | 407 (35.3%) | 268 (31.2%) | 268 (27.8%) | 313 (32.6%) | 366 (38.4%) | 167 (45.6%) | |
| SBP [mmHg] | 126.2 (20.9) | 124.1 (20.1) | 122.4 (19.4) | 119.9 (18.7) | 122.6 (19.6) | 127.4 (20.2) | 131.6 (22) | |
| DBP [mmHg] | 73.1 (10.1) | 71.8 (10) | 70.5 (9.8) | 70.5 (9.5) | 71.5 (10.2) | 72.7 (9.9) | 73.4 (10.8) | |
| BMI [kg/m2] | 29.9 (5.6) | 28 (5) | 26.8 (4.5) | 26.8 (4.6) | 27.9 (5) | 28.9 (5.2) | 30.7 (6.1) | |
| Total cholesterol [mg/dl] | 193.3 (36.5) | 192.8 (34.4) | 195.8 (33.9) | 195.4 (34.6) | 193.5 (35.1) | 194.6 (34.5) | 189.4 (35.9) | |
| LDL [mg/dl] | 118.7 (32.5) | 116.4 (30) | 116 (29.4) | 117.4 (29.4) | 117.1 (31.1) | 117.8 (30.6) | 113.3 (32.5) | |
| HDL [mg/dl] | 49.8 (14.5) | 50 (14.6) | 53.7 (15.7) | 51.3 (14.4) | 50.6 (14.9) | 51.4 (15.6) | 51.6 (15.6) | |
| Treatment with statins, % | 136 (13.2%) | 187 (16.2%) | 129 (16.1%) | 129 (13.4%) | 133 (13.8%) | 158 (16.6%) | 74 (20.2%) | |
| Current smokers, % | 158 (15.4%) | 114 (9.9%) | 101 (9.5%) | 125 (13%) | 116 (12.1%) | 97 (10.2%) | 35 (9.6%) | |
| Former smokers, % | 361 (35.1%) | 415 (36.1%) | 399 (37.6%) | 349 (36.2%) | 343 (35.8%) | 359 (37.6%) | 124 (34%) | |
| GFR [ml/min/1.73m2] | 88.9 (16) | 86 (15.6) | 83 (15.2) | 86.4 (14.8) | 86.4 (15.6) | 86 (15.8) | 83.1 (18.2) | |
| Calcium [mg/dl] | 9.6 (0.4) | 9.6 (0.4) | 9.7 (0.4) | 9.7 (0.4) | 9.7 (0.4) | 9.6 (0.4) | 9.6 (0.5) | |
| Phosphorus [mg/dl] | 3.7 (0.5) | 3.6 (0.5) | 3.7 (0.5) | 3.8 (0.5) | 3.7 (0.5) | 3.6 (0.5) | 3.5 (0.5) | |
| IL-6 [IU/ml] | 38 (13.5) | 40.4 (17.1) | 41.9 (23.1) | 39.5 (14.9) | 39.9 (22.5) | 40.4 (13.1) | 41.5 (25.3) | |
| CRP [mg/l] | 1.7 (1.3) | 1.4 (1) | 1.3 (1) | 1.3 (1.1) | 1.4 (1.1) | 1.5 (1.2) | 1.7 (1.1) | |
Abbreviations:
SBP = systolic blood pressure; DBP = diastolic blood pressure; BMI = body-mass index; LDL = low-density lipoprotein; HDL = high-density lipoprotein; GFR = glomerular filtration rate; IL-6 = interleukin-6; CRP = C-reactive protein.